Entries by Andrew Humphreys

, , , , , , , , , , ,

Just more than half of U.S. adults have gotten at least one Covid-19 vaccine dose – CDC

Just more than half of U.S. adults have received at least one Covid-19 vaccine dose, data from the U.S. Centers for Disease Control and Prevention showed on April 18, with nearly 130 million people aged 18 years or more having received their first shot.

, , , , , , , , , , ,

Blood type not a Covid-19 risk factor in U.S.; inhaled asthma drug may keep mild illness from worsening

According to separate studies, blood type does not affect susceptibility to Covid-19 in U.S. patients and an inhaled steroid commonly used to treat asthma can help keep patients with mild Covid-19 from getting sicker.

, , , , ,

7 Steps to a Seamless and Collaborative Implementation of Remote Site Access Technology

Florence Healthcare’s Senior Implementation Manager Amanda Korey presents a roadmap that not only fosters collaboration between sites, sponsors and CROs, but also results in robust user adoption across all stakeholder groups.

, , , , , , , , , , , , , , ,

Drug companies to face first opioid trial following pandemic delays

Four drugmakers, including Johnson & Johnson and Teva Pharmaceutical Industries Ltd., will go to trial on April 19 over claims they helped fuel an opioid crisis that has resulted in nearly 500,000 overdose deaths in the United States.

, , , , , , ,

U.S. FDA Approves Opdivo in Combination with Chemotherapy for Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma

U.S. Food and Drug Administration Approves Opdivo®(nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma — Opdivo is the first […]